Junshi Biosciences Announces Financial Results for Six Months Ended June 30, 2020 and Provides Corporate Updates
ACN Newswire Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization
Read More